These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 17875723)

  • 1. Targeting human medulloblastoma: oncolytic virotherapy with myxoma virus is enhanced by rapamycin.
    Lun XQ; Zhou H; Alain T; Sun B; Wang L; Barrett JW; Stanford MM; McFadden G; Bell J; Senger DL; Forsyth PA
    Cancer Res; 2007 Sep; 67(18):8818-27. PubMed ID: 17875723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myxoma virus is a novel oncolytic virus with significant antitumor activity against experimental human gliomas.
    Lun X; Yang W; Alain T; Shi ZQ; Muzik H; Barrett JW; McFadden G; Bell J; Hamilton MG; Senger DL; Forsyth PA
    Cancer Res; 2005 Nov; 65(21):9982-9990. PubMed ID: 16267023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myxoma virus virotherapy for glioma in immunocompetent animal models: optimizing administration routes and synergy with rapamycin.
    Lun X; Alain T; Zemp FJ; Zhou H; Rahman MM; Hamilton MG; McFadden G; Bell J; Senger DL; Forsyth PA
    Cancer Res; 2010 Jan; 70(2):598-608. PubMed ID: 20068158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncolytic virotherapy synergism with signaling inhibitors: Rapamycin increases myxoma virus tropism for human tumor cells.
    Stanford MM; Barrett JW; Nazarian SH; Werden S; McFadden G
    J Virol; 2007 Feb; 81(3):1251-60. PubMed ID: 17108021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treating brain tumor-initiating cells using a combination of myxoma virus and rapamycin.
    Zemp FJ; Lun X; McKenzie BA; Zhou H; Maxwell L; Sun B; Kelly JJ; Stechishin O; Luchman A; Weiss S; Cairncross JG; Hamilton MG; Rabinovich BA; Rahman MM; Mohamed MR; Smallwood S; Senger DL; Bell J; McFadden G; Forsyth PA
    Neuro Oncol; 2013 Jul; 15(7):904-20. PubMed ID: 23585629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reovirus prolongs survival and reduces the frequency of spinal and leptomeningeal metastases from medulloblastoma.
    Yang WQ; Senger D; Muzik H; Shi ZQ; Johnson D; Brasher PM; Rewcastle NB; Hamilton M; Rutka J; Wolff J; Wetmore C; Curran T; Lee PW; Forsyth PA
    Cancer Res; 2003 Jun; 63(12):3162-72. PubMed ID: 12810644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncolytic efficacy of recombinant vesicular stomatitis virus and myxoma virus in experimental models of rhabdoid tumors.
    Wu Y; Lun X; Zhou H; Wang L; Sun B; Bell JC; Barrett JW; McFadden G; Biegel JA; Senger DL; Forsyth PA
    Clin Cancer Res; 2008 Feb; 14(4):1218-27. PubMed ID: 18281557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of systemically administered oncolytic vaccinia virotherapy for malignant gliomas is enhanced by combination therapy with rapamycin or cyclophosphamide.
    Lun XQ; Jang JH; Tang N; Deng H; Head R; Bell JC; Stojdl DF; Nutt CL; Senger DL; Forsyth PA; McCart JA
    Clin Cancer Res; 2009 Apr; 15(8):2777-88. PubMed ID: 19351762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting gallbladder cancer: oncolytic virotherapy with myxoma virus is enhanced by rapamycin in vitro and further improved by hyaluronan in vivo.
    Weng M; Gong W; Ma M; Chu B; Qin Y; Zhang M; Lun X; McFadden G; Forsyth P; Yang Y; Quan Z
    Mol Cancer; 2014 Apr; 13():82. PubMed ID: 24725816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapamycin enhances the activity of oncolytic herpes simplex virus against tumor cells that are resistant to virus replication.
    Fu X; Tao L; Rivera A; Zhang X
    Int J Cancer; 2011 Sep; 129(6):1503-10. PubMed ID: 21128236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor activity of the rapamycin analog CCI-779 in human primitive neuroectodermal tumor/medulloblastoma models as single agent and in combination chemotherapy.
    Geoerger B; Kerr K; Tang CB; Fung KM; Powell B; Sutton LN; Phillips PC; Janss AJ
    Cancer Res; 2001 Feb; 61(4):1527-32. PubMed ID: 11245461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myxoma virus-mediated oncolysis of ascites-derived human ovarian cancer cells and spheroids is impacted by differential AKT activity.
    Correa RJ; Komar M; Tong JG; Sivapragasam M; Rahman MM; McFadden G; Dimattia GE; Shepherd TG
    Gynecol Oncol; 2012 May; 125(2):441-50. PubMed ID: 22306204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic Combination of Oncolytic Virotherapy and Immunotherapy for Glioma.
    Tang B; Guo ZS; Bartlett DL; Yan DZ; Schane CP; Thomas DL; Liu J; McFadden G; Shisler JL; Roy EJ
    Clin Cancer Res; 2020 May; 26(9):2216-2230. PubMed ID: 32019860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncolytic measles virus prolongs survival in a murine model of cerebral spinal fluid-disseminated medulloblastoma.
    Studebaker AW; Hutzen B; Pierson CR; Russell SJ; Galanis E; Raffel C
    Neuro Oncol; 2012 Apr; 14(4):459-70. PubMed ID: 22307474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An oncolytic measles virus-sensitive Group 3 medulloblastoma model in immune-competent mice.
    Lal S; Carrera D; Phillips JJ; Weiss WA; Raffel C
    Neuro Oncol; 2018 Nov; 20(12):1606-1615. PubMed ID: 29912438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myxoma virus oncolysis of primary and metastatic B16F10 mouse tumors in vivo.
    Stanford MM; Shaban M; Barrett JW; Werden SJ; Gilbert PA; Bondy-Denomy J; Mackenzie L; Graham KC; Chambers AF; McFadden G
    Mol Ther; 2008 Jan; 16(1):52-9. PubMed ID: 17998900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myxoma virus combined with rapamycin treatment enhances adoptive T cell therapy for murine melanoma brain tumors.
    Thomas DL; Doty R; Tosic V; Liu J; Kranz DM; McFadden G; Macneill AL; Roy EJ
    Cancer Immunol Immunother; 2011 Oct; 60(10):1461-72. PubMed ID: 21656158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of medulloblastoma with oncolytic measles viruses expressing the angiogenesis inhibitors endostatin and angiostatin.
    Hutzen B; Bid HK; Houghton PJ; Pierson CR; Powell K; Bratasz A; Raffel C; Studebaker AW
    BMC Cancer; 2014 Mar; 14():206. PubMed ID: 24646176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intratumoral coadministration of hyaluronidase enzyme and oncolytic adenoviruses enhances virus potency in metastatic tumor models.
    Ganesh S; Gonzalez-Edick M; Gibbons D; Van Roey M; Jooss K
    Clin Cancer Res; 2008 Jun; 14(12):3933-41. PubMed ID: 18559615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncolytic measles virus efficacy in murine xenograft models of atypical teratoid rhabdoid tumors.
    Studebaker AW; Hutzen B; Pierson CR; Shaffer TA; Raffel C; Jackson EM
    Neuro Oncol; 2015 Dec; 17(12):1568-77. PubMed ID: 25838138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.